Warner Bros. Discovery, Inc.
WBD is under a signed $31/share cash acquisition by Paramount, so the live question is not intrinsic value but whether a 1.5% spread compensates for escalating regulatory risk over the next nine days.
The trade in WBD is now merger arbitrage, not business valuation. Paramount agreed to buy the company for $31/share in cash, and WBD trades at $30.54, leaving only $0.46 of upside if the deal closes on schedule. With an expected close on 2026-09-30, a holder is essentially underwriting a few more days of regulatory and remedy risk for a very small absolute return. That setup argues for HOLD, not because the stand-alone assets are uninteresting, but because the payoff has become capped while the downside remains open-ended.
The fundamental backdrop matters mainly for break-price support. It is better than the market gave WBD credit for a year ago, but still not good enough to shrug off a busted deal. Streaming is clearly the bright spot. Q2 2026 streaming revenue topped $3B for the first time, streaming adjusted EBITDA reached $512M and grew more than 60% y/y, and management pointed to double-digit distribution growth, better bundling economics, and its best retention year ever. Licensing also remains healthy, especially for older library titles. Those are real improvements and they help explain why the quant engine can justify a $34.68 stand-alone value, even with a mediocre 41/100 quality score.
The problem is that the weaker pieces have not gone away. FY2025 revenue fell 5.1% to $37.3B, linear advertising was down nearly 30% in Q2, and management still cannot make Studios dependable. The company admitted recent films underperformed and 2026 is light on tentpoles, with the bigger content slate only arriving in 2027 when film count rises from 14 to 19. That leaves little near-term earnings cushion if regulators force concessions, delay the close, or break the transaction entirely. The balance sheet also limits flexibility, with $32.0B of debt, 3.40x debt/EBITDA, a 0.78 current ratio, and just $0.6B of FCF in FY2025.
The market is mispricing neither a hidden growth story nor a cheap broken asset. It is pricing a pending cash deal with a modest chance of failure. For existing holders, waiting a few more days for $31 is defensible. For new buyers, the spread does not pay enough for the headline risk now that California scrutiny has intensified. What this case depends on is simple: regulatory clearance, no material remedy that impairs economics, and an on-time close. Without those, the stock immediately becomes a stand-alone judgment call on a leveraged media turnaround that is improving, but still uneven.
Best realistic shareholder outcome is straightforward completion at the signed $31 cash price because the deal caps upside.
On fundamentals alone the engine supports $34.68, but in practice the stock should trade to the signed $31 cash takeout if closing risk fades in the final days.
Deal breaks or is pushed out by remedies, and the market refocuses on $32.0B debt, 3.40x debt/EBITDA, weak linear ads, and inconsistent Studio execution.
Quant call aligns with analyst consensus (Hold: 0 buy / 3 hold / 0 sell).
Never, ever invest in the present.
Forward earnings power matters mainly as downside support if the deal breaks. On the stand-alone path, trailing valuation looks undemanding at 1.93x sales versus peers at 2.1x, and the engine's $34.68 target sits above the deal price, but the market cannot realize that upside while the $31 cash consideration caps the stock. Over the next 3 to 5 years, WBD's moat is improving in streaming through retention, bundling, and library monetization, but AI is more double-edged than helpful here: it can lower localization, marketing, and ad-tech costs, yet it also raises content discovery competition and does not solve the hit-driven nature of film or the structural decline in linear TV. Regulation is the dominant secular force right now because it determines whether shareholders receive cash in days or revert to owning a leveraged, mixed-quality media asset.
- Signed deal value is $31/share cash versus current price $30.54, leaving only a $0.46 gross spread.
- Recent merger news turned negative on 2026-08-24, including California canceling planned settlement talks and reports it may seek TV channel sales from Paramount.
- Operating fundamentals are mixed: FY2025 revenue fell 5.1% to $37.3B, but Q2 2026 streaming revenue topped $3B for the first time and streaming adjusted EBITDA reached $512M, up more than 60% y/y.
- The signed consideration is explicit and near-dated, $31/share cash with an expected close of 2026-09-30, and the stock is just 0.3% below its 52-week high at $30.63, showing the market still assigns high odds to completion.
- Streaming is improving into the close window: Q2 2026 EBITDA was $1.40B at a 16.0% margin, up from 13.3% in Q1, and streaming adjusted EBITDA of $512M rose more than 60% y/y.
- Management's medium-term asset quality is better than the trailing P&L suggests, with streaming revenue above $3B for the first time, distribution growth back to double digits, and 2027 content support from a ramp from 14 films in FY26 to 19 films in FY27.
- Technical positioning is not hostile to the deal close, with short interest only 2.89%, 3.2 days-to-cover, and options gamma in a positive regime with zero-gamma at $28.64, below spot.
- The payoff is small relative to closing risk: the spread is only 1.5%, while headline risk has increased materially in the last 30 days around antitrust and state-level remedies.
- Core business quality remains uneven, with a 41/100 quality score, cash flow quality 24, profitability 10, and only $0.6B of FCF against $32.0B of total debt.
- Studios continue to miss internal expectations, and management said, "The quarter, obviously, in the film business wasn't what we expected." That matters because 2026 is described as light on tentpoles, limiting near-term earnings support if the deal slips.
- Advertising remains weak in linear, down nearly 30% in Q2, with international trends worse than Q1 and weak visibility, which raises downside if the transaction breaks and the market must reprice WBD on stand-alone fundamentals.
| Metric | Value | Context |
|---|---|---|
| Pending acquisition | $31/share cash | Announced 2026-02-27 by Paramount, expected close 2026-09-30 |
| Current price | $30.54 | Implies a $0.46 gross spread to signed deal price |
| Quant price target | $34.68 | 13.5% vs current, High confidence, basis: sales_quality_blend |
| FY2025 revenue | $37.3B | -5.1% YoY, showing the legacy decline is still larger than growth engines on a consolidated basis |
| FY2025 EPS | $0.29 | 106.3% YoY improvement, but from a depressed base |
| Operating margin | 3.5% | Improved from prior FY -25.5%, but still thin for a content owner of this scale |
| Net margin | 1.9% | Profits remain modest relative to revenue base |
| Leverage | Debt/EBITDA 3.40 | Total debt $32.0B, still elevated for a cyclical media business |
| Free cash flow | $0.6B | Weak versus debt load and only modestly above buybacks of $0.4B |
| Valuation | P/S 1.93 | Below peer average 2.1, while P/E is N/A versus peer average 21.0 |
| 52-week position | -0.3% vs 52-week high | 52-week range $17.08-$30.63, showing the deal has largely pulled the stock to the cash offer |
| Quality / Risk | 41/100 | 54/100 | Moderate risk, with particularly weak sub-scores in profitability 10 and growth potential 11 |
The biggest risk is deal break or delay: with the stock at $30.54 versus a $31 cash bid, even a modest standalone re-rating toward pre-deal or stress-case levels could wipe out far more than the remaining $0.46 spread.
Regulatory and settlement developments ahead of the expected 2026-09-30 close, more than the 2026-11-05 earnings date, are the next decisive catalyst.
Ownership is concentrated, with the top three institutions holding 61.9%, which usually dampens squeeze dynamics and pushes trading toward event-probability pricing. Short interest is only 2.89%, or 68.8M shares, with 3.2 days-to-cover, so there is no large forced-buying setup. Options positioning is mildly supportive because the gamma regime is positive and zero-gamma sits at $28.64, below spot, but that matters less than merger headlines when the stock is -0.3% from its 52-week high and trading to a hard takeout price.
Q2 2026 streaming revenue topped $3B for the first time; adjusted EBITDA was $512M, up more than 60% y/y, with lower churn and the best retention year expected in 2026.
Performance was below expectations in Q2 2026; management is trying to rebalance risk by taking film releases from 14 in FY26 to 19 in FY27.
Linear advertising was down nearly 30% in Q2 2026, hurt by the NBA comparison and weaker international markets.
International trends matter disproportionately right now because management flagged worse than Q1 ad trends outside the U.S. and weaker visibility for the rest of the year.
Streaming momentum strengthened, but Studios remained below expectations.
Execution is mixed, not cleanly strong. Back on the 2024 Q3 call, management said it was highly confident it would "meaningfully exceed" $1B of DTC EBITDA in 2025 and that Q4 2024 DTC growth and EBITDA would remain strong, and the current evidence supports that the streaming side did deliver real progress: by Q2 2026, streaming revenue had exceeded $3B for the first time, adjusted EBITDA hit $512M, up more than 60% y/y, and retention/churn trends improved materially. But Studios has been a repeat weak point across both periods: in 2024 management admitted Studios was "subpar relative to our internal expectations", and in 2026 the same pattern persisted with management again saying "The quarter, obviously, in the film business wasn't what we expected." The earnings record reinforces the inconsistency, with large misses on 2026-05-06 and 2026-02-25, offset by major beats on 2026-08-06 and 2025-08-07. Credibility is reasonable on streaming operations, lower on forecasting consolidated earnings and Studio cadence.
That trajectory looks very solid for the remainder of the year.
2027 is arguably our best year yet.
We're making 14 films this year, ramping up to 19 next year, and we're very confident that we're going to be able to maintain that larger number.
The quarter, obviously, in the film business wasn't what we expected.
We are looking at a 2026 year where the trends give sort of high confidence that we're going to have our best year ever in terms of retention and lower churn in 2026.
WBD's moat is its content library, global distribution relationships, and franchises that still travel across film, TV, streaming, licensing, and games. That moat is real but not clean: HBO, Harry Potter, DC, and the legacy Warner library support retention and licensing demand, yet the durability is lower than a software or platform moat because returns still depend on keeping the content machine full and because linear distribution economics are eroding. The moat looks stronger in streaming and licensing than in theatrical or legacy networks.
Capital allocation has improved but is still constrained by leverage. WBD generated only $0.6B of FCF in FY2025, spent $0.3B on capex, bought back $0.4B of stock, and paid no dividend, which is a modestly aggressive posture given $32.0B of debt and 3.40x debt/EBITDA. If the deal were not pending, the stronger use of cash would still be debt reduction until the balance sheet gets closer to management's older 2.5x to 3.0x leverage target.
Rated HOLD, High conviction. WBD is no longer a clean fundamental stock call because the signed $31 cash acquisition dominates the setup. The spread from $30.54 is too small to chase aggressively with regulatory friction rising, but existing holders can still justify waiting for the expected 2026-09-30 close. A move to BUY would require either a materially wider spread with no new regulatory damage or clear evidence that closing risk has fallen sharply. A move to SELL would require another tangible deterioration in merger clearance odds, because the downside in a busted deal is much larger than the remaining upside to the cash bid.
≣ Full research note tap to expand
Executive Summary
HOLD, High conviction. WBD has agreed to be acquired by Paramount for $31/share in cash, expected to close on 2026-09-30, and the stock at $30.54 is effectively pinned to that outcome. The spread is only $0.46, or about 1.5%, while the latest news flow has turned worse with California scrutiny and possible asset-sale demands. Rated HOLD, High conviction: existing holders can rationally wait for the merger consideration, but fresh money is not being paid enough for the deal risk.
Investment Thesis
The trade in WBD is now merger arbitrage, not business valuation. Paramount agreed to buy the company for $31/share in cash, and WBD trades at $30.54, leaving only $0.46 of upside if the deal closes on schedule. With an expected close on 2026-09-30, a holder is essentially underwriting a few more days of regulatory and remedy risk for a very small absolute return. That setup argues for HOLD, not because the stand-alone assets are uninteresting, but because the payoff has become capped while the downside remains open-ended.
The fundamental backdrop matters mainly for break-price support. It is better than the market gave WBD credit for a year ago, but still not good enough to shrug off a busted deal. Streaming is clearly the bright spot. Q2 2026 streaming revenue topped $3B for the first time, streaming adjusted EBITDA reached $512M and grew more than 60% y/y, and management pointed to double-digit distribution growth, better bundling economics, and its best retention year ever. Licensing also remains healthy, especially for older library titles. Those are real improvements and they help explain why the quant engine can justify a $34.68 stand-alone value, even with a mediocre 41/100 quality score.
The problem is that the weaker pieces have not gone away. FY2025 revenue fell 5.1% to $37.3B, linear advertising was down nearly 30% in Q2, and management still cannot make Studios dependable. The company admitted recent films underperformed and 2026 is light on tentpoles, with the bigger content slate only arriving in 2027 when film count rises from 14 to 19. That leaves little near-term earnings cushion if regulators force concessions, delay the close, or break the transaction entirely. The balance sheet also limits flexibility, with $32.0B of debt, 3.40x debt/EBITDA, a 0.78 current ratio, and just $0.6B of FCF in FY2025.
The market is mispricing neither a hidden growth story nor a cheap broken asset. It is pricing a pending cash deal with a modest chance of failure. For existing holders, waiting a few more days for $31 is defensible. For new buyers, the spread does not pay enough for the headline risk now that California scrutiny has intensified. What this case depends on is simple: regulatory clearance, no material remedy that impairs economics, and an on-time close. Without those, the stock immediately becomes a stand-alone judgment call on a leveraged media turnaround that is improving, but still uneven.
Key Metrics
| Metric | Value | Context | |
|---|---|---|---|
| Pending acquisition | $31/share cash | Announced 2026-02-27 by Paramount, expected close 2026-09-30 | |
| Current price | $30.54 | Implies a $0.46 gross spread to signed deal price | |
| Quant price target | $34.68 | 13.5% vs current, High confidence, basis: sales_quality_blend | |
| FY2025 revenue | $37.3B | -5.1% YoY, showing the legacy decline is still larger than growth engines on a consolidated basis | |
| FY2025 EPS | $0.29 | 106.3% YoY improvement, but from a depressed base | |
| Operating margin | 3.5% | Improved from prior FY -25.5%, but still thin for a content owner of this scale | |
| Net margin | 1.9% | Profits remain modest relative to revenue base | |
| Leverage | Debt/EBITDA 3.40 | Total debt $32.0B, still elevated for a cyclical media business | |
| Free cash flow | $0.6B | Weak versus debt load and only modestly above buybacks of $0.4B | |
| Valuation | P/S 1.93 | Below peer average 2.1, while P/E is N/A versus peer average 21.0 | |
| 52-week position | -0.3% vs 52-week high | 52-week range $17.08-$30.63, showing the deal has largely pulled the stock to the cash offer | |
| Quality / Risk | 41/100 | 54/100 | Moderate risk, with particularly weak sub-scores in profitability 10 and growth potential 11 |
Financial Strength
The balance sheet is serviceable but not comfortable on a stand-alone basis. WBD has done the hard work of moving from deeply negative operating margins to 3.5% in FY2025, yet that still leaves little room for error when debt is $32.0B and leverage is 3.40x EBITDA. The weak point is cash generation: $0.6B of FCF is low for a company with this debt burden and content intensity, and a 0.78 current ratio limits near-term flexibility. The positive read is that streaming operating leverage is real and Q2 margin improved to 16.0%, but if the merger fails, the company would still need several more quarters of consistent FCF and deleveraging to earn a more bullish stand-alone stance.
Competitive Position
WBD's moat is its content library, global distribution relationships, and franchises that still travel across film, TV, streaming, licensing, and games. That moat is real but not clean: HBO, Harry Potter, DC, and the legacy Warner library support retention and licensing demand, yet the durability is lower than a software or platform moat because returns still depend on keeping the content machine full and because linear distribution economics are eroding. The moat looks stronger in streaming and licensing than in theatrical or legacy networks.
Management & Guidance
Current guidance is mixed by segment. Management is positive on streaming, with distribution growth in the double-digit to low-teens range for H2 2026, confidence in the best retention year ever, and another European bundle due this fall. The weaker piece is Studios, where the long-term adjusted EBITDA target is still over $3B, but the path is back-end loaded because 2026 is light on tentpoles and the slate only scales from 14 films this year to 19 next year. Given the earnings record, including major misses in February and May 2026, guidance deserves more credit in streaming than in consolidated earnings timing.
Segment Analysis
- Streaming / DTC (Not disclosed in the provided FY2025 segment split): Q2 2026 streaming revenue topped $3B for the first time; adjusted EBITDA was $512M, up more than 60% y/y, with lower churn and the best retention year expected in 2026.
- Studios (Not disclosed in the provided FY2025 segment split): Performance was below expectations in Q2 2026; management is trying to rebalance risk by taking film releases from 14 in FY26 to 19 in FY27.
- Networks / Linear advertising (Not disclosed in the provided FY2025 segment split): Linear advertising was down nearly 30% in Q2 2026, hurt by the NBA comparison and weaker international markets.
- Geography (Geographic revenue split not provided): International trends matter disproportionately right now because management flagged worse than Q1 ad trends outside the U.S. and weaker visibility for the rest of the year.
Capital Allocation
Capital allocation has improved but is still constrained by leverage. WBD generated only $0.6B of FCF in FY2025, spent $0.3B on capex, bought back $0.4B of stock, and paid no dividend, which is a modestly aggressive posture given $32.0B of debt and 3.40x debt/EBITDA. If the deal were not pending, the stronger use of cash would still be debt reduction until the balance sheet gets closer to management's older 2.5x to 3.0x leverage target.
Management Execution & Track Record
Execution is mixed, not cleanly strong. Back on the 2024 Q3 call, management said it was highly confident it would "meaningfully exceed" $1B of DTC EBITDA in 2025 and that Q4 2024 DTC growth and EBITDA would remain strong, and the current evidence supports that the streaming side did deliver real progress: by Q2 2026, streaming revenue had exceeded $3B for the first time, adjusted EBITDA hit $512M, up more than 60% y/y, and retention/churn trends improved materially. But Studios has been a repeat weak point across both periods: in 2024 management admitted Studios was "subpar relative to our internal expectations", and in 2026 the same pattern persisted with management again saying "The quarter, obviously, in the film business wasn't what we expected." The earnings record reinforces the inconsistency, with large misses on 2026-05-06 and 2026-02-25, offset by major beats on 2026-08-06 and 2025-08-07. Credibility is reasonable on streaming operations, lower on forecasting consolidated earnings and Studio cadence.
Positioning & Flows
Ownership is concentrated, with the top three institutions holding 61.9%, which usually dampens squeeze dynamics and pushes trading toward event-probability pricing. Short interest is only 2.89%, or 68.8M shares, with 3.2 days-to-cover, so there is no large forced-buying setup. Options positioning is mildly supportive because the gamma regime is positive and zero-gamma sits at $28.64, below spot, but that matters less than merger headlines when the stock is -0.3% from its 52-week high and trading to a hard takeout price.
Bull Case
- The signed consideration is explicit and near-dated, $31/share cash with an expected close of 2026-09-30, and the stock is just 0.3% below its 52-week high at $30.63, showing the market still assigns high odds to completion.
- Streaming is improving into the close window: Q2 2026 EBITDA was $1.40B at a 16.0% margin, up from 13.3% in Q1, and streaming adjusted EBITDA of $512M rose more than 60% y/y.
- Management's medium-term asset quality is better than the trailing P&L suggests, with streaming revenue above $3B for the first time, distribution growth back to double digits, and 2027 content support from a ramp from 14 films in FY26 to 19 films in FY27.
- Technical positioning is not hostile to the deal close, with short interest only 2.89%, 3.2 days-to-cover, and options gamma in a positive regime with zero-gamma at $28.64, below spot.
Bear Case
- The payoff is small relative to closing risk: the spread is only 1.5%, while headline risk has increased materially in the last 30 days around antitrust and state-level remedies.
- Core business quality remains uneven, with a 41/100 quality score, cash flow quality 24, profitability 10, and only $0.6B of FCF against $32.0B of total debt.
- Studios continue to miss internal expectations, and management said, "The quarter, obviously, in the film business wasn't what we expected." That matters because 2026 is described as light on tentpoles, limiting near-term earnings support if the deal slips.
- Advertising remains weak in linear, down nearly 30% in Q2, with international trends worse than Q1 and weak visibility, which raises downside if the transaction breaks and the market must reprice WBD on stand-alone fundamentals.
Valuation & Price Target
Engine price target $34.68 (+13.5% vs current), High confidence.
- P/S Multiple: $33.82 (45% weight)
- Quality-adjusted: $28.34 (20% weight)
- DCF: $182.29 (1% weight)
The rating stays at HOLD, in line with the quant baseline, but for a different reason. The engine's $34.68 target and 13.5% upside are not actionable while a signed $31 cash acquisition caps the stock. On stand-alone fundamentals, one could argue for more than Hold because 1.93x sales is below the 2.1x peer average and streaming is improving, but the market cannot capture that upside before the transaction resolves. Sell-side consensus is also Hold, but that is low-signal context only. The practical question is event math, and 1.5% spread is not enough to upgrade the name despite some fundamental support below.
Risk Assessment
Risk score 54/100 (Moderate). The biggest risk is deal break or delay: with the stock at $30.54 versus a $31 cash bid, even a modest standalone re-rating toward pre-deal or stress-case levels could wipe out far more than the remaining $0.46 spread.
The Bottom Line
Rated HOLD, High conviction. WBD is no longer a clean fundamental stock call because the signed $31 cash acquisition dominates the setup. The spread from $30.54 is too small to chase aggressively with regulatory friction rising, but existing holders can still justify waiting for the expected 2026-09-30 close. A move to BUY would require either a materially wider spread with no new regulatory damage or clear evidence that closing risk has fallen sharply. A move to SELL would require another tangible deterioration in merger clearance odds, because the downside in a busted deal is much larger than the remaining upside to the cash bid.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr